Inactive Instrument

Analyst Reco. Perrigo Company Nasdaq

Equities

US7142901039

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 25	Sector Update: Health Care Stocks Decline Late Afternoon	MT
Apr. 25	Perrigo Receives Binding Offer to Sell HRA Pharma Rare Diseases Business for Up to $295 Million	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Piper Sandler Raises Perrigo's Price Target to $39 From $35, Maintains Overweight Rating	Apr. 08	MT
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsors	Apr. 04	RE
Multiple CVS Caremark Plans to Cover Perrigo's Opill at No Cost	Apr. 04	MT
JPMorgan Cuts Price Target on Perrigo to $41 From $48, Maintains Overweight Rating	Feb. 28	MT
Canaccord Genuity Starts Perrigo at Buy With $49 Price Target	23-03-07	MT
Raymond James Adjusts Perrigo Price Target to $43 From $42, Maintains Outperform Rating	23-03-06	MT
Raymond James Adjusts Price Target on Perrigo Company to $42 From $48, Maintains Outperform Rating	22-11-09	MT
Argus Upgrades Perrigo to Buy From Hold; Price Target is $46	22-09-14	MT
Wells Fargo Raises Perrigo to Overweight From Equalweight, Price Target to $54 From $48	22-09-06	MT
PERRIGO REPORTS FIRST QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS FROM CONTINUING OPERATIONS, RAISES GUIDANCE	22-05-11	PR
Raymond James Adjusts Perrigo's Price Target to $48 from $55, Keeps Outperform Rating	22-05-04	MT
Raymond James Adjusts Price Target on Perrigo to $55 From $59, Maintains Outperform Rating	21-11-11	MT
PERRIGO : Raymond James Upgrades Perrigo to Outperform from Market Perform, Sets $59 Price Target	21-10-14	MT
PERRIGO : Jefferies Upgrades Perrigo to Buy from Hold, Adjusts PT to $63 from $45	21-09-30	MT
PERRIGO : Jefferies Upgrades Perrigo to Buy from Hold, Adjusts Price Target to $63 from $45	21-09-30	MT
PERRIGO : RBC Cuts Price Target on Perrigo to $48 From $51 After Q2 Results Miss Expectations; Sector Perform Rating Maintained	21-08-12	MT
Health Care Slips As Traders Rotate Into Rate-Sensitive Sectors -- Health Care Roundup	21-08-11	DJ
PERRIGO : Morgan Stanley Adjusts Perrigo Company PT to $45 From $53, Maintains Equal Weight Rating	21-03-05	MT
PERRIGO : RBC Capital Adjusts Perrigo's Price Target to $51 From $49, Maintains Sector Perform Rating	21-03-02	MT
PERRIGO : RBC Capital Downgrades Perrigo Company to Sector Perform From Outperform, Adjusts PT to $49 From $59	21-01-06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Perrigo Company Nasdaq

Equities

US7142901039

Analyst Reco.

Filters